In type 1 diabetes, there is an association between adiponectin levels and motor (but not sensory) nerve conduction velocity, whereas in type 2 patients, the adiponectin levels correlate with both motor and sensory nerve velocities after controlling for several confounders (age, sex, time since diagnosis of diabetes, HbA1c, waist circumference, height, total cholesterol, hypertension, current smoking, physical activity, use of lipid-lowering medication, use of nonsteroidal anti-inflammatory drugs, history of myocardial infarction and/or stroke). Here, ADIPOQ is linked to stroke disorder.